Clinical trial
Intrathecal Rituximab in Progressive Multiple Sclerosis
NCT02545959 is registered in ClinicalTrials.gov with Centre Hospitalier de PAU as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intrathecal Rituximab in Progressive Multiple Sclerosis
- Lead sponsor
- Centre Hospitalier de PAU
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2015
- Completion date
- September 2, 2019
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.